Sign in

Evangelos Giampazolias

@giampazolias.bsky.social
1.8K followers 1.6K following 13 posts

Group Leader, Cancer Immunosurveillance Lab @cruk-mi.bsky.social. Interested in how #HostMicrobiome interactions & #CellDeath dictate #CancerImmunity. 🔗 www.cruk.manchester.ac.uk/Our-Resea…

PostsRepliesMedia
Evangelos Giampazolias @giampazolias.bsky.social · 22/06/2026
Privileged to present our work @cruk-mi.bsky.social at #Cancer&theHost @cancergrand.bsky.social on how the #microbiome🦠 shapes #immunity💥 long before cancer develops. Inspiring talks from #CarolineDive, #AdrianHayday and @johannajoyce.bsky.social . Thanks to the organisers for a fantastic meeting!
1160
Evangelos Giampazolias @giampazolias.bsky.social · 22/06/2026
Honoured to speak at #EACR2026 in Budapest on how #HostMicrobiome🦠 interactions shape #CancerImmunity💥 @cruk-mi.bsky.social. Thanks to @yardenasamuels.bsky.social and the organisers, and congratulations to @johannajoyce.bsky.social on becoming President of the #EACR. 🎉 #CancerImmunology #Microbiome
190
Evangelos Giampazolias @giampazolias.bsky.social · 16/06/2026
Proud of #SwaraPatel and #EmmaWest for representing the Lab so brilliantly at the 19th International PhD Student Cancer Conference (IPSCC) @nkinl.bsky.social in Amsterdam, delivering an excellent oral presentation and fantastic poster. #CancerImmunosurveillanceGroup @cruk-mi.bsky.social
080
Evangelos Giampazolias @giampazolias.bsky.social · 16/06/2026
Had an amazing time speaking at @pintofscience.uk about how the #GutMicrobiome 🦠 shapes #AntiTumourImmunity 💥 Thanks to my #Lab @cruk-mi.bsky.social, the organisers, the speakers, everyone who attended and the #TeamManchester🐝 @lydiabeckeriii.bsky.social @manchester.ac.uk @mcrcnews.bsky.social
0144
Reposted by Evangelos Giampazolias
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 21/05/2026
Congratulations to Samra Turajlić and Tim Somervaille on their election to the Academy of Medical Sciences! 🎉 Their election reflects the achievements of our scientists, as well as the collaborative research environment and powerful facilities in Manchester that enable our work to benefit patients!
1103
Reposted by Evangelos Giampazolias
The Francis Crick Institute @crick.ac.uk · 19/05/2026
Researchers at the Crick have uncovered how lung tumours can hijack the activity of nearby nerves to weaken the body’s immune response. This research was led by Ya-Hsuan Ho and Giacomo Bregni, with corresponding author Leanne Li. www.crick.ac.uk/news/2026-05...
crick.ac.uk
Nerve signals disrupt immune response to lung cancer
Sensory nerve activity disrupts how immune cells are organised within lung tumours, weakening the immune response.
1103
Reposted by Evangelos Giampazolias
Caetano Reis e Sousa @reisesousalab.bsky.social · 20/05/2026
Delighted that our paper is out @natcancer.nature.com. Research led by Tom Castro-Dopico in partnership with Adendra Therapeutics reporting on a means to increase presentation of antigens from cancer cells. Read it for free at www.nature.com/articles/s43...
nature.com
Coupling dead cell recognition to Fcγ receptors augments anticancer immunity - Nature Cancer
Castro-Dopico et al. report the design of reagents to bridge F-actin and Fcγ receptors, endowing a range of antigen-presenting cells with the ability to cross-present antigens from dead tumor cells an...
13211
Reposted by Evangelos Giampazolias
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 22/04/2026
🚨 We're looking for an Associate Director for Strategy & Partnerships — a pivotal leadership role that will help define how we connect, collaborate, and amplify our impact on a global stage of cancer research! Apply below by 26.05.2026! 👇 www.cruk.manchester.ac.uk/career/mi-26... Salary - ~£80,000
094
Reposted by Evangelos Giampazolias
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 13/04/2026
🚨 Open for applications - Director of Scientific Core Facilities & Services! Shape the strategic future of our core facilities and work with leading experts on cutting-edge cancer discovery and translational research 🧑‍🔬🔬🧪 💷 ~£100,000 ⏰ 17.5.2026 Apply 👉 www.cruk.manchester.ac.uk/career/mi-26...
A collage of images show imaging technologies, stained cells and a mouse in a specially designed research habitat
044
Reposted by Evangelos Giampazolias
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 17/03/2026
Exciting new research from our Group Leader @sylvaindelaunay.bsky.social and Pierre Close at @universitedeliege.bsky.social shows how modifying a tRNA can alter the immune profile of #melanoma - exposing it to the #ImmuneSystem Read the full story here: www.cruk.manchester.ac.uk/news/new-res...
cruk.manchester.ac.uk
New Research: TRNA Modification Triggers Anti-tumour Immunity | Cancer Research UK Manchester Institute
New research has uncovered an unexpected way to stimulate the immune system against cancer: by subtly disrupting how tumour cells manufacture their proteins.
064
Evangelos Giampazolias @giampazolias.bsky.social · 14/01/2026
❗Cross-presentation shapes neoantigen visibility and cancer immunogenicity in #NatureImmunology🤯 www.nature.com/articles/s41... Huge congratulations @drjonlim.bsky.social 🥂 Inspired and so lucky to have you in #Manchester 🐝 Congratulations to #OliverSchulz, @reisesousalab.bsky.social , @crick.ac.uk
nature.com
Client Challenge
192
Reposted by Evangelos Giampazolias
Caetano Reis e Sousa @reisesousalab.bsky.social · 02/01/2026
Absolutely delighted that our latest paper is out today @natimmunol.nature.com. It has taken five years to uncover a role for cross-presentation in shaping the immune visibility of tumour antigens. A labour of love led by @drjonlim.bsky.social and Oliver Schulz. Great start of 2026!
0269
Reposted by Evangelos Giampazolias
Jon Lim, FRCP PhD @drjonlim.bsky.social · 27/12/2025
🎙️ Enjoyed speaking with Salome Chkheidze, a medical student at Tbilisi State Medical University & journalist at Medscriptum, about precision oncology and the evolving opportunities (and challenges! of cell therapy in solid tumours. Many thanks for the interview feature 👇
medscriptum.org
Overcoming Barriers to Cell Therapy - From Spatial Immunology to the Scalability Gap - MedScriptum
In this interview, Dr. Lim unpacks the evolving role of cell therapies and reveals the gaps between promise and practice that call for fresh thinking.
021
Reposted by Evangelos Giampazolias
Jon Lim, FRCP PhD @drjonlim.bsky.social · 29/12/2025
🎙️ Great to hear Samra @turajliclab.bsky.social and @manifest-cirrp.bsky.social featured on BBC Radio 5 Live 👇
021
Reposted by Evangelos Giampazolias
Jon Lim, FRCP PhD @drjonlim.bsky.social · 12/12/2025
Hear more about RISE + why tackling safety/toxicity in advanced therapies is centre to our programme. We're humbled to hear from Elkie Mellor, who generously shared her lived experience. Voices like hers are a powerful reminder of why this work matters & will continue to motivate everything we do.
christie.nhs.uk
Major study launched to make advanced cancer treatments safer for patients
A major new UK study, led by The Christie NHS Foundation Trust and The University of Manchester, has been launched to help patients with cancer better tolerate cutting-edge immunotherapy treatments li...
072
Reposted by Evangelos Giampazolias
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 04/11/2025
Our Institute Director, Professor Samra Turajlić, will be giving a public talk at @crick.ac.uk 💬Crick Crash Course: Immunotherapy 📅Wed 19th Nov 🕙10am 📌Crick Institute, London For full details and to book: www.eventbrite.co.uk/e/crick-cras... @turajliclab.bsky.social #Immunotherapy
Graphic advertising the Immunotherapy Crash Course, with a photograph of Prof Turajlić, a QR code for booking and the details of the event (as in the main text of the message) along with a background image of cells and tissues
063
Reposted by Evangelos Giampazolias
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 30/10/2025
You've got just a few days left to submit your proposal to join us as a new Group Leader 📅 Applications close 2nd November Package includes: 🪙Multi-year funding 🧪Core Facility Access 🥼 #Postdoc & #PhD positions 🤝Mentorship Visit our website to apply: www.cruk.manchester.ac.uk/career/new-g...
11013
Reposted by Evangelos Giampazolias
Jon Lim, FRCP PhD @drjonlim.bsky.social · 07/10/2025
🎓 Fully-funded 4-yr MRC PhD @officialuom.bsky.social! Join a world-class team exploring how the microenvironment drives CRS in CAR-T therapy. 🌍 Open globally | 💥 Translational science 🗓️ Apply by 8 Nov 2025 🔗 www.findaphd.com/phds/project... #PhDOpportunity #TeamManchester 🐝 @uom-dcs.bsky.social
043
Reposted by Evangelos Giampazolias
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 17/10/2025
We are excited to announce that our #PhD Student Recruitment is open for applications! For full details of all projects and information on how to apply, visit: www.cruk.manchester.ac.uk/phd-student-... 📅 Applications close 28th November & we look forward to hearing from you!
147
Reposted by Evangelos Giampazolias
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 22/10/2025
You have just *4 days* left to apply for a #Postdoc position with the fab @sylvaindelaunay.bsky.social Study how diet affects #RNA modifications to drive cancer progression with: 🔵In vivo models 🔵Patient samples 🔵Long-read #Nanopore seq 🔵 #CRISPR screens www.cruk.manchester.ac.uk/career/mi-25...
cruk.manchester.ac.uk
MI/25/57 Postdoctoral Scientist | Cancer Research UK Manchester Institute
A postdoctoral position is available in the laboratory of Sylvain Delaunay to study how diet affects RNA modifications to drive cancer progression.
042
Reposted by Evangelos Giampazolias
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 24/09/2025
Exciting news - we are recruiting new Group Leaders! 🥼 We are seeking to appoint exceptional early-career scientists & clinician scientists as #GroupLeaders to develop bold, innovative, high-impact #CancerResearch programmes Full details on our website: www.cruk.manchester.ac.uk/career/new-g...
youtu.be
Group Leader Recruitment at the Cancer Research UK Manchester Institute
YouTube video by CRUK Manchester Institute
42118
Reposted by Evangelos Giampazolias
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 15/10/2025
Exciting new research from our Cancer Inflammation and Immunity Group led by @santiagozelenay.bsky.social on the counterintuitive effects of steroids to enhance responses to immunotherapy in #melanoma Visit our website for more on this paper published today in Cancer Discovery
cruk.manchester.ac.uk
Glucocorticoids Unleash Immune-dependent Melanoma Control Through Inhibition Of The GARP/TGF β Axis | Cancer Research UK Manchester Institute
This study uncovers a surprising role for GCs in triggering CD8+ T cell–dependent tumour control through downregulation of GARP and thus TGF β signalling.
272
Reposted by Evangelos Giampazolias
Elizabeth McKenna @elizsmckenna.bsky.social · 22/10/2025
Now online in Cancer Discovery @aacrjournals.bsky.social: Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGF β Axis - by Charles Earnshaw, @santiagozelenay.bsky.social, and colleagues doi.org/10.1158/2159... @cruk-mi.bsky.social
064
Reposted by Evangelos Giampazolias
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 23/10/2025
Just 3 days left to apply for a #postdoc position with @clausjorgensen.bsky.social and the Systems Oncology group 🥼Study a novel therapeutic target in #PancreaticCancer relating to the #TumourMicroenvironment For full details & to apply please visit: www.cruk.manchester.ac.uk/career/mi-25...
Image shows graphics of calendars and clocks, text reads

3 days to go - time is running out - apply for this role today!

MI/25/33_2 Postdoctoral Scientist
Systems Oncology Group
Apply by 26th October
075
Reposted by Evangelos Giampazolias
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 03/10/2025
One great opportunity is for a self-motivated, innovative, meticulous and organised candidate who is keen to work in a dynamic laboratory undertaking cutting edge research with Prof @clausjorgensen.bsky.social as a #PostdoctoralScientist Full details at: www.cruk.manchester.ac.uk/career/mi-25...
cruk.manchester.ac.uk
MI/25/33_2 Postdoctoral Scientist | Cancer Research UK Manchester Institute
Dr Claus Jorgensen, Group Leader of the Systems Oncology Group, is looking for a Postdoctoral Scientist to join his group. This is a great opportunity for a self-motivated, innovative, meticulous and ...
143
Reposted by Evangelos Giampazolias
Jon Lim, FRCP PhD @drjonlim.bsky.social · 09/09/2025
People make places. Proud to be part of #TeamManchester 🐝, and to work alongside inspiring colleagues who consistently go above and beyond - always putting patients first. 🏆 The Christie NHS Foundation Trust @mcrcnews.bsky.social www.bbc.co.uk/news/article...
bbc.co.uk
Best and worst-performing NHS Trusts in England named
Critics question the usability of new league tables meant to inform the public and let them exercise choice.
073
Reposted by Evangelos Giampazolias
Caetano Reis e Sousa @reisesousalab.bsky.social · 04/08/2025
My "Crash Course in …Immunology" is now posted on YouTube youtu.be/nBC9vvlTxF8. Taken from a public lecture @crick.ac.uk on history and basic concepts in immunity. Aimed at the lay public and those seeking an introductory overview.
youtu.be
The Past, Present and Future of Immunology Research – with Caetano Reis e Sousa
YouTube video by Francis Crick Institute
03710
Reposted by Evangelos Giampazolias
Caetano Reis e Sousa @reisesousalab.bsky.social · 01/08/2025
Delighted that our paper describing cDC1 states and their distribution in mouse tumours is out today in @eurjimmunol.bsky.social. Many congratulations to Cécile Piot who led this work and brought it to conclusion! onlinelibrary.wiley.com/doi/10.1002/...
onlinelibrary.wiley.com
3317
Evangelos Giampazolias @giampazolias.bsky.social · 02/09/2025
Thrilled to welcome #SamraTurajlić to the #ManchesterFamily 🐝! We are excited for her vision and leadership in driving world-class, multidisciplinary cancer research, and proud to be part of this journey together!
0222
Evangelos Giampazolias @giampazolias.bsky.social · 15/07/2025
I'm deeply honoured to receive the BACR/AstraZeneca Young Scientist Frank Rose Award in recognition of my cancer research. Grateful to @thebacr.bsky.social @astra-zeneca.bsky.social ‬ #Mentors & #Colleagues whose support has shaped this journey. My reflections👇 🔗 www.bacr.org.uk/news/2025-ba...
109815
Reposted by Evangelos Giampazolias
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 29/05/2025
May is #SunAwarenessMonth prompting thoughts of #SkinCancer & #VitaminD - but there's more! 🧪 Group leader @giampazolias.bsky.social spoke to BBC Science Focus about the relationship between Vitamin D, the gut #microbiome & cancer #immunity Read the story: www.cruk.manchester.ac.uk/news/institu...
043
Reposted by Evangelos Giampazolias
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 18/06/2025
We are delighted to announce, along with Cancer Research UK (@cancerresearchuk.org), The University of Manchester (@manchester.ac.uk) and The Christie NHS Foundation Trust, the appointment of Professor Samra Turajlić as our new Director! ⭐ Full story here: www.cruk.manchester.ac.uk/news/profess...
Announcement image - dark blue background with coloured overlapping circles
 
Top shows the Cancer Research UK Manchester Institute Logo
 
Centre shows a photograph of Professor Samra Turajlić
 
Text says:
 
"A warm welcome to our new Director, Professor Samra Turajlić, from all staff and students at the Cancer Research UK Manchester Institute"
05611
Reposted by Evangelos Giampazolias
William Hill @drwilliamhill.bsky.social · 06/06/2025
Thrilled to announce I'm moving to Manchester to lead the Cancer Origins group! If you're interested in how mutations and exposures drive tumourigenesis — come join the adventure
54012
Reposted by Evangelos Giampazolias
Jon Lim, FRCP PhD @drjonlim.bsky.social · 02/05/2025
🚀 In the past 6 months or so, we have been busy setting up #MANIFESTuk + getting it up & running 🇬🇧. Delighted to share an overview of our Consortium's vision & ambitions to drive the future of #CancerImmunotherapy: aacrjournals.org/cancerdiscov... @zaydtippu.bsky.social @manifest-cirrp.bsky.social
aacrjournals.org
MANIFEST: Multiomic Platform for Cancer Immunotherapy
Summary:. Immunotherapy has revolutionized survival outcomes for many patients diagnosed with cancer. However, biomarkers that can reliably distinguish treatment responders from nonresponders, predict...
186
Evangelos Giampazolias @giampazolias.bsky.social · 02/05/2025
Great Lab! Don’t miss the opportunity and apply👇
055
Reposted by Evangelos Giampazolias
Jon Lim, FRCP PhD @drjonlim.bsky.social · 14/04/2025
💡Inspiring to be in amongst esteemed colleagues at BSI Cancer Immunotherapies Summit today at The Royal Society. Happy to share our vision & ambitions for #MANIFESTuk + how we can work collaboratively to tackle some of the biggest questions in immuno-oncology. @manifest-cirrp.bsky.social
132
Reposted by Evangelos Giampazolias
Sylvain Delaunay @sylvaindelaunay.bsky.social · 11/04/2025
💥Exciting #Postdoc opportunity in my lab at @cruk-mi.bsky.social to study the role of #RNADynamics in cancer progression! ⏰Deadline: 07/05/25 Apply 👇 www.cruk.manchester.ac.uk/career/mi-24... ⏩ Please share this with your network. #CancerResearch #RNADynamics #RNAmodification #CRUK #postdoc
01512
Reposted by Evangelos Giampazolias
The French DC Society - Club Francophone des DC (CFCD) @frenchdcsociety.bsky.social · 07/04/2025
⚠️ SAVE THE DATE ⚠️ CFCD meeting - December 4th-5th 2025 Unveiling the future of Dendritic Cell and Macrophage biology in health and disease 🔥🔥🔥 Venue : Institut Curie in Paris Amazing keynotes by Yasmine Belkaid (Institut Pasteur) Dan Litmann (NYU) Registrations open soon
173
Reposted by Evangelos Giampazolias
Jon Lim, FRCP PhD @drjonlim.bsky.social · 04/04/2025
🚨 Final day to send in your application to join @giampazolias.bsky.social & the Cancer Immunosurveillance group @cruk-mi.bsky.social. Don’t miss this great opportunity! @mcrcnews.bsky.social
044
Evangelos Giampazolias @giampazolias.bsky.social · 26/03/2025
💥Exciting new #postdoc opportunities in my lab at @cruk-mi.bsky.social i.bsky.social to study #NutrientHostMicrobiome interactions in #CancerImmunity in mice and humans. #CancerImmunology#MucosalImmunology#Microbiome ⏰Deadline: 4 April 2025 Apply👇 www.cruk.manchester.ac.uk/career/mi-24... ⏩RT
12118
Reposted by Evangelos Giampazolias
Cancer Research UK Manchester Institute @cruk-mi.bsky.social · 06/03/2025
We are recruiting #postdoctoral scientists to join @giampazolias.bsky.social and our Cancer Immunosurveillance group 🧪🥼🧫🦠 For full details of the position, please visit our website: www.cruk.manchester.ac.uk/career/mi-24... Closing date: 4th April #OncoSky #CanSky #CancerResearch #microbiome
Job Advert for Postdoctoral Scientist in the Cancer Immunosurveillance Group

Salary £37,000-£44,852 dependent upon qualifications and experience

Job ID MI/24/55-2

Apply by 4th April 2025
01512
Evangelos Giampazolias @giampazolias.bsky.social · 17/02/2025
Interested in how #Inflammation shapes #CancerImmunity? There is no better Lab to answer this💥 #Postdoc position in @santiagozelenay.bsky.social Lab. If you are looking for exciting research and excellent mentor don't miss this opportunity and apply now👇 www.cruk.manchester.ac.uk/career/mi-25...
cruk.manchester.ac.uk
MI/25/01 – Postdoctoral Scientist – Cancer Inflammation And Immunity Group | Cancer Research UK Manchester Institute
0106
Evangelos Giampazolias @giampazolias.bsky.social · 17/02/2025
Huge congratulations @marianapdc.bsky.social for defending your PhD thesis. I couldn't be prouder of you for what you have achieved in @reisesousalab.bsky.social all these years. It was an honour working with you and is a privilege to be your friend! This is just the beginning of a stellar career!🍾🥂
141
Reposted by Evangelos Giampazolias
Lydia Becker Institute @lydiabeckeriii.bsky.social · 16/01/2025
Come join us at the Becker! Our Deputy Cellular Immunology Branch Lead Dr Madhvi Menon has a fantastic Postdoc opportunity in her lab 👇 #ImmunoSky
066
Reposted by Evangelos Giampazolias
Jon Lim, FRCP PhD @drjonlim.bsky.social · 04/01/2025
📚 Our review on the management of toxicities of cell therapy for solid cancers is now out in print in #ESMO ‘s flagship IO journal ESMO IOTECH. 👉 incl. TILs, TCR-T & CAR-T + associated tx e.g. IL-2 & NMA-LD. 🔗 www.esmoiotech.org/article/S259... @sophiawongyn.bsky.social @fbmh-uom.bsky.social
🔗 https://www.esmoiotech.org/article/S2590-0188(24)00034-0/fulltext
0114
Reposted by Evangelos Giampazolias
Jon Lim, FRCP PhD @drjonlim.bsky.social · 20/12/2024
We are hiring! #MANIFESTuk 3 more positions now open: 💻 Postdoctoral Fellow – Computational Modelling 🧬 Senior Bioinformatician (Genomics) 🔬 Senior Bioinformatician (Imaging) @manifest-cirrp.bsky.social @crick.ac.uk Check out below for more info 👇
1105
Reposted by Evangelos Giampazolias
Jon Lim, FRCP PhD @drjonlim.bsky.social · 18/12/2024
📢 Shout out to @giampazolias.bsky.social - we made it to the 2️⃣0️⃣2️⃣4️⃣ year-end “Crick Five Stories”. @crick.ac.uk #CancerImmunology #HostMicrobiome 🔗 Check out our original paper #OpenAccess: www.science.org/doi/10.1126/...
science.org
Vitamin D regulates microbiome-dependent cancer immunity
A role for vitamin D in immune modulation and in cancer has been suggested. In this work, we report that mice with increased availability of vitamin D display greater immune-dependent resistance to tr...
0185
Reposted by Evangelos Giampazolias
Jon Lim, FRCP PhD @drjonlim.bsky.social · 10/12/2024
👨‍⚕️🏥👩‍⚕️ Are you a #YoungOncologist? Interested in a 6-8 week sabbatical? Consider applying for #ESMO Clinical Unit Visit Fellowship to join us in Manchester at our Experimental Cancer Medicines + Advanced Immunotx & Cell Tx teams. @mcrcnews.bsky.social 🗓️ Due 24 Jan 2025 🔗 www.esmo.org/career-devel...
074
Evangelos Giampazolias @giampazolias.bsky.social · 28/11/2024
📢 Last few days to apply for #ERCResearch funded postdoc positions available in my Lab at @cruk-mi.bsky.social to study how the #GutMicrobiome instructs #CancerImmunity. ⏰ Deadline: 1 December 2024 Don't miss this opportunity‼️ Apply 👇 www.cruk.manchester.ac.uk/recruitment/...
cruk.manchester.ac.uk
01510
Reposted by Evangelos Giampazolias
Jon Lim, FRCP PhD @drjonlim.bsky.social · 26/11/2024
⏰ Final call! 🧑‍🔬 Last week to apply for this fantastic opportunity to work with the exceptional @giampazolias.bsky.social at @cruk-mi.bsky.social. #TeamManchester To apply (deadline 1 Dec 2024): www.cruk.manchester.ac.uk/recruitment/...
cruk.manchester.ac.uk
Index - CrukMi.RecruitmentHr.Ui
075